Literature DB >> 19768373

Self-help group and medication overuse headache: preliminary data.

Elisa Sancisi1, Marialuisa Rausa, Stefano Zanigni, Sabina Cevoli, Andrea Norcini Pala, Marianna Nicodemo, Daniela Grimaldi, Pasquale Montagna, Pietro Cortelli, Giulia Pierangeli.   

Abstract

The objective of the study is to investigate the benefits of joining a self-help group for patients with medication overuse headache (MOH). A self-help group is a voluntary gathering of a small number of persons who share a common problem. Little is known about support groups for people with chronic non-malignant pain such as MOH. Eight patients with refractory MOH attended a self-help group twice a month. During the meetings, patients were asked to focus on their headache experiences. Our data showed an increase in resourcefulness in coping with pain and a reduction in cephalalgiophobia. All patients reported general benefits in sharing their headache-related problems. No differences were found for headache frequency or analgesic overuse. To our knowledge, this is the first report on a self-help group for patients with MOH. Joining a self-help group can help patients develop positive attitudes to managing pain.

Entities:  

Mesh:

Year:  2009        PMID: 19768373     DOI: 10.1007/s10072-009-0131-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

Review 1.  Theoretical perspectives on the relation between catastrophizing and pain.

Authors:  M J Sullivan; B Thorn; J A Haythornthwaite; F Keefe; M Martin; L A Bradley; J C Lefebvre
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

2.  Chronic daily headache: is analgesic overuse a cause or a consequence?

Authors:  Richard B Lipton; Marcelo E Bigal
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

3.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

4.  The development of a support group organization for headache sufferers.

Authors:  J Klapper; J Stanton; M Seawell
Journal:  Headache       Date:  1992-04       Impact factor: 5.887

5.  The development and impact of a chronic pain support group: a qualitative and quantitative study.

Authors:  V Subramaniam; M W Stewart; J F Smith
Journal:  J Pain Symptom Manage       Date:  1999-05       Impact factor: 3.612

6.  Pain-specific beliefs, perceived symptom severity, and adjustment to chronic pain.

Authors:  M P Jensen; P Karoly
Journal:  Clin J Pain       Date:  1992-06       Impact factor: 3.442

7.  The role of coping in adjustment to phantom limb pain.

Authors:  A Hill; C A Niven; C Knussen
Journal:  Pain       Date:  1995-07       Impact factor: 6.961

8.  Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study.

Authors:  J-A Zwart; G Dyb; K Hagen; S Svebak; J Holmen
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

9.  Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.

Authors:  Elliott A Schulman; Alvin E Lake; Peter J Goadsby; B Lee Peterlin; Sherry E Siegel; Herbert G Markley; Richard B Lipton
Journal:  Headache       Date:  2008-05-14       Impact factor: 5.887

10.  Cephalalgiaphobia: a possible specific phobia of illness.

Authors:  Mario F P Peres; Juliane P P Mercante; Vera Z Guendler; Felipe Corchs; Marcio A Bernik; Eliova Zukerman; Stephen D Silberstein
Journal:  J Headache Pain       Date:  2007-02-19       Impact factor: 7.277

View more
  2 in total

1.  Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study.

Authors:  Giulia Giannini; Stefano Zanigni; Daniela Grimaldi; Roberto Melotti; Giulia Pierangeli; Pietro Cortelli; Sabina Cevoli
Journal:  J Headache Pain       Date:  2013-06-10       Impact factor: 7.277

2.  OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse.

Authors:  Edoardo Caronna; Victor José Gallardo; Natalia Hernández-Beltrán; Marta Torres-Ferrus; Patricia Pozo-Rosich
Journal:  Front Neurol       Date:  2018-10-16       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.